Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Kelli S. Walters · SciRah

Researcher profile · Semantic Scholar

Kelli S. Walters

Share profile

Kelli S. Walters — researcher profile on SciRah

h-index: 6
Works: 16
Citations: 405

Most-cited papers

Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.
C. Acharya, David S. Hsu, C. Anders, A. Anguiano +14 more
2008Journal of the American Medical Association (JAMA)114 citations
Semantic Scholar
Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer.
David S. Hsu, B. Balakumaran, C. Acharya, Vanja Vlahović +10 more
2007Journal of Clinical Oncology105 citations
Semantic Scholar
An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer
Kelly H. Salter, C. Acharya, Kelli S. Walters, Richard C. Redman +10 more
2008PLoS ONE87 citations Open access
Semantic Scholar
Age- and sex-specific genomic profiles in non-small cell lung cancer.
W. Mostertz, M. Stevenson, C. Acharya, I-Ping Chan +6 more
2010Journal of the American Medical Association (JAMA)62 citations
Semantic Scholar
Characterizing the Clinical Relevance of an Embryonic Stem Cell Phenotype in Lung Adenocarcinoma
M. Stevenson, W. Mostertz, C. Acharya, William Y. Kim +9 more
2009Clinical Cancer Research19 citations Open access
Semantic Scholar
Retraction. Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. J Clin Oncol 25:4350–7, 2007.
David S. Hsu, B. Balakumaran, C. Acharya, Vanja Vlahović +10 more
2010Journal of Clinical Oncology12 citations Open access
Semantic Scholar
Retraction: Acharya CR, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA. 2008;299(13):1574-1587.
C. Acharya, David S. Hsu, C. Anders, A. Anguiano +14 more
2012Journal of the American Medical Association (JAMA)2 citations
Semantic Scholar
Characterizing the clinical relevance of epithelial mesenchymal transition (EMT) in human tumors.
K. Higgins, Kelli S. Walters, A. Potti
20102 citations
Semantic Scholar
Retraction: Characterizing the Clinical Relevance of an Embryonic Stem Cell Phenotype in Lung Adenocarcinoma
M. Stevenson, W. Mostertz, C. Acharya, William Y. Kim +9 more
2012Clinical Cancer Research1 citations
Semantic Scholar
Characterizing the clinical relevance of an embryonic stem cell phenotype in lung adenocarcinoma.
M. Stevenson, W. Mostertz, C. Acharya, Kelli S. Walters +6 more
2009Journal of Clinical Oncology1 citations
Semantic Scholar
Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced non- small cell lung cancer (NSCLC)
C. Acharya, David S. Hsu, B. Balakumaran, Kelli S. Walters +6 more
20071 citations
Semantic Scholar
Retraction: Acharya CR, et al. Gene expression signatures, clinicopathological features, and
C. Acharya, David S. Hsu, C. Anders, A. Anguiano +14 more
20170 citations
Semantic Scholar
Retraction: An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer
Kelly H. Salter, C. Acharya, Kelli S. Walters, Richard C. Redman +10 more
2011PLoS ONE0 citations Open access
Semantic Scholar
Integration of mRNA and microRNA profiles as prognostic and predictive markers in lung adenocarcinoma.
J. Strickler, William Mostertz, William Y. Kim, Kelli S. Walters +5 more
2009Journal of Clinical Oncology0 citations
Semantic Scholar
487 Gene Expression Profiles for Prognosis Provide a Novel Approach for Selection of Individualized Therapies in Early Stage Colon Carcinoma
K. Garman, M. Grade, C. Acharya, Kelli S. Walters +5 more
20080 citations
Semantic Scholar
Integration of clinico-pathologic variables, mRNA, and microRNA profiles represents an optimal strategy to predict sensitivity to chemotherapeutic agents in breast cancer
Kelly H. Salter, B. A. Perez, C. Acharya, Kelli S. Walters +6 more
20080 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Potti×16
Invite
A. Potti — researcher profile on SciRah
C. Acharya×15
Invite
C. Acharya — researcher profile on SciRah
J. Nevins×10
Invite
J. Nevins — researcher profile on SciRah
C. Anders×8
Invite
C. Anders — researcher profile on SciRah

×8

Invite

H. Dressman — researcher profile on SciRah

Invite

K. Garman — researcher profile on SciRah

David S. Hsu×7

Invite

David S. Hsu — researcher profile on SciRah

Invite

A. Anguiano — researcher profile on SciRah

Kelly H. Salter×6

Invite

Kelly H. Salter — researcher profile on SciRah

Invite

S. Tuchman — researcher profile on SciRah

Richard C. Redman×5

Invite

Richard C. Redman — researcher profile on SciRah

Sayan Mukherjee×5

Invite

Sayan Mukherjee — researcher profile on SciRah